KAN.ST
Price:
$0.2975
Market Cap:
$36.05M
Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.
Industry
Biotechnology
IPO Date
2011-02-25
Stock Exchange
STO
Ticker
KAN.ST
According to Kancera AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 8.02. This represents a change of -11.01% compared to the average of 9.01 of the last 4 quarters.
The mean historical Current Ratio of Kancera AB (publ) over the last ten years is 5.45. The current 8.02 Current Ratio has changed 14.62% with respect to the historical average. Over the past ten years (40 quarters), KAN.ST's Current Ratio was at its highest in in the June 2021 quarter at 13.26. The Current Ratio was at its lowest in in the December 2019 quarter at 0.60.
Average
5.45
Median
5.34
Minimum
0.60
Maximum
10.74
Discovering the peaks and valleys of Kancera AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 935.41%
Maximum Annual Current Ratio = 10.74
Minimum Annual Increase = -74.78%
Minimum Annual Current Ratio = 0.60
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 10.61 | 300.27% |
| 2023 | 2.65 | -63.17% |
| 2022 | 7.20 | -33.01% |
| 2021 | 10.74 | 72.83% |
| 2020 | 6.22 | 935.41% |
| 2019 | 0.60 | -74.78% |
| 2018 | 2.38 | -30.13% |
| 2017 | 3.41 | -44.22% |
| 2016 | 6.11 | 33.26% |
| 2015 | 4.58 | 31.70% |
The current Current Ratio of Kancera AB (publ) (KAN.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.82
5-year avg
7.48
10-year avg
5.45
Kancera AB (publ)’s Current Ratio is greater than RLS Global AB (publ) (3.63), less than CombiGene AB (publ) (17.47), greater than NeoDynamics AB (publ) (1.06), greater than Emplicure AB (publ) (3.52), greater than FRISQ Holding AB (publ) (2.40), greater than Amniotics AB (publ) (1.17), greater than Diagonal Bio AB (publ) (1.94), greater than Pharmiva AB (publ) (5.46), greater than Idogen AB (publ) (1.67), greater than Coala-Life Group AB (publ) (0.83),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.63 | $35.70M | |
| 17.47 | $48.91M | |
| 1.06 | $29.35M | |
| 3.52 | $46.47M | |
| 2.40 | $46.74M | |
| 1.17 | $14.76M | |
| 1.94 | $20.20M | |
| 5.46 | $12.93M | |
| 1.67 | $12.79M | |
| 0.83 | $24.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kancera AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kancera AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Kancera AB (publ)'s Current Ratio?
How is the Current Ratio calculated for Kancera AB (publ) (KAN.ST)?
What is the highest Current Ratio for Kancera AB (publ) (KAN.ST)?
What is the 3-year average Current Ratio for Kancera AB (publ) (KAN.ST)?
What is the 5-year average Current Ratio for Kancera AB (publ) (KAN.ST)?
How does the current Current Ratio for Kancera AB (publ) (KAN.ST) compare to its historical average?